Quantum Dots in Ocular Surface: A Systematic Review
Abstract
The current advancements in quantum dot-based ocular surface applications identify critical gaps in existing research. A systematic search was conducted following PRISMA guidelines. Articles were retrieved from PubMed and Scopus using keywords including "quantum dots," "semiconductor nanocrystals," "ocular surface," "tear film," "cornea," "conjunctiva," "lacrimal glands," and "meibomian glands" with Boolean conjunctions. A total of 232 studies were initially selected based on titles and abstracts. After removing duplicates and screening, 21 studies were selected for review. A variety of QDs, including carbon, graphene, silicon, cadmium and gold-based, have been explored for bioimaging and therapeutic applications targeting the ocular surface. Carbon and silicon-based QDs are the most biocompatible. Surface functionalization of these QDs facilitates targeted imaging of tear film layers, conjunctiva, and cornea with stable fluorescence and minimal toxicity. QDs can also be antimicrobial, anti-inflammatory, and scavenge reactive oxygen species which might be used for the treatment of dry eye disease. Although cadmium-based QDs exhibit superior fluorescence, their cytotoxicity limits their clinical application. The optical properties of QDs are influenced by physicochemical properties such as particle size, surface charge, and surface functionalization. QDs represent a promising class of nanoscale materials for diagnostic and therapeutic applications on the ocular surface. While…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.